Synapse News

2 of 28

Innovation Parks, Clinical Infrastructure and Supportive Networks are three ways smart site selection is helping life sciences companies turn innovation into commercialisation

Making a smart site selection could drive the commercialisation of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialisation. Three areas in particular, are making site selection easier: innovation parks, clinical infrastructure and…

September 23, 2022 | Alex Muggah

SOPHIE participant Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants

Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants. The lead investor in the financing was…

September 21, 2022 | Alex Muggah

Adapsyn Bioscience enters into strategic collaboration with Evotec

Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug…

September 21, 2022 | Alex Muggah

OmniaBio Groundbreaking Ceremony 

Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing…

September 9, 2022 | Alex Muggah

Startups need cash, time, and connections

Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. If new healthcare innovations don’t integrate with existing systems, there is little to no chance of mass adoption. As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in…

August 24, 2022 | Alex Muggah

AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego

AtomVie Global Radiopharma Inc. (AtomVie) today announced the successful closing of its Series A financing with Avego Management, LLC (“Avego”), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Organization) for the development, manufacturing, and global distribution of…

August 24, 2022 | Alex Muggah

Innovative Health Diagnostics and Hamilton-based AIMA Laboratories Collaborate to Develop New, Revolutionary At-Home Test to Detect Endometriosis

Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person access to accurate, clinical testing by providing testing when and where it matters most, announced today a new partnership with AIMA Laboratories (AIMA), a Hamilton-based FemTech company dedicated to developing new products that fill current gaps in…

August 23, 2022 | Alex Muggah

Renowned burn surgeon leaves Toronto for Hamilton to reboot General’s burn trauma unit, develop ‘skin printing’ stem cell tech, and become new VP Research at Hamilton Health Sciences

Dr. Marc Jeschke joined McMaster University as a professor of surgery, and was also recently named vice-president of research at Hamilton Health Sciences and medical director of its burns unit. The burn trauma surgeon and scientist is moving to Hamilton from Toronto to become medical director of the burn unit at the General Hospital on […]

July 29, 2022 | Alex Muggah

Invest Ontario features Hamilton’s OmniaBio – Shaping the Future of Regenerative Medicine

Since the 1963 discovery of stem cells by two University of Toronto researchers, Drs. Ernest McCulloch and James Till, Ontario has been at the forefront of regenerative medicine discovery and development. Dr. Peter Zandstra C.M., Chief Scientific Officer, and Dr. Michael May, President and Chief Executive Officer of CCRM, recognized a need to…

July 27, 2022 | Alex Muggah